loading

Recent events

GLuna Shrimp owner Gabriel Luna

AdvertisementX
AdvertisementX

Sustainability

Merck to acquire Elanco’s aquaculture business for $1.3bn

Merck Animal Health gains an 'innovative portfolio of medicines and vaccines,' two related aqua manufacturing facilities in Canada and Vietnam, and a research facility in Chile

By Neil Ramsden | Feb. 5, 2024 12:01 GMT
Credit: Elanco
Related

BASF, Merck join Sustainable Shrimp Partnership

MSD Animal Health buys DNA-based food traceability company

MSD launches strep vaccine in Latin America

MSD launches strep vaccine in Latin America

Merck acquires Vaki from Pentair as latter sheds aquaculture divisions

US judge rejects Amendment 80 fleet’s challenge to halibut bycatch rule

High Liner maintains strong margins despite sales drops in Q3

AdvertisementX

Merck Animal Health, known as MSD Animal Health outside of the US and Canada, has signed a definitive agreement to acquire the aqua business of Elanco Animal Health for $1.3 billion in cash. [...]

Want to keep reading?

Sign up for a trial to have full access to our articles for 7 days!

Argentine red shrimp market ‘still weak’ with Chinese imports down

Antarctica Advisors: Cooke’s Copeinca acquisition will reshape Peruvian fishing landscape

Another case of oyster MSX suspected in Atlantic Canada

Norway, Chile salmon spot prices climb a little, Scottish flat

AdvertisementX

Contact the author [email protected]

Stay on the pulse

Get recommendations, data, editor’s picks, and the latest news from around the seafood world straight to your inbox.

Select your interests

Please select at least one newsletter d indicates our daily newsletters | 2w indicates twice-weekly | All others sent weekly All briefings are sent weekly, unless otherwise indicated
Region
Breaking news
Jobs
Species
Topic

Fill in your details

Please select at least one newsletter!
  • (eg new industry reports, prices data)
  • (eg subscription or report early birds)
  • (eg advertising, trade shows news)
How we handle your data We never share, sell or distribute our subscribers’ data. You may at any time unsubsribe from our newsletters, and request that we erase all information stored about you. Please check our Privacy policy for more details.

We use MailChimp and HubSpot as our email campaign platforms. By subscribing, you agree that the information you provide will be transferred to MailChimp and HubSpot for processing in accordance with their privacy policies (MailChimp privacy policy, HubSpot privacy policy) and terms (MailChimp terms, HubSpot terms).

Thank you. Please check your inbox to confirm your selection and start receiving newsletters.

Cookies on Undercurrent News

We use cookies for performance, security and analytics. To stop seeing this banner click Accept, or select Manage cookies to set your preferences and privacy settings.